Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.3900 (1.89%) ($5.2000 - $5.6500) on Fri. May. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 33.62% (three month average) | RSI | 34 | Latest Price | $5.3900(1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -12.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XOP(36%) OIH(35%) DIA(31%) XLE(31%) IVE(29%) | Factors Impacting CAPR price | CAPR will decline at least -16.81% in a week (0% probabilities). VIXM(-25%) VXX(-22%) TLT(-21%) UUP(-17%) UNG(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -16.81% (StdDev 33.62%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
Resistance Level | $6.23 | 5 Day Moving Average | $5.32(1.32%) | 10 Day Moving Average | $6.12(-11.93%) | 20 Day Moving Average | $6.23(-13.48%) | To recent high | -36.6% | To recent low | 1.9% | Market Cap | $106m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |